| Bioactivity | Milrinone lactate is a potent inotropic dilating agent. Milrinone lactate shows simultaneous positive inotropic and vasodilating activities. Milrinone lactate promotes reduction of SVR and PVR in patients with DCM and NYHA class III and IV of heart failure. Milrinone lactate has the potential for the research of cardiovascular function after cardiac surgery and in septic shock[1][2]. |
| Name | Milrinone lactate |
| CAS | 100286-97-3 |
| Formula | C12H9N3O.xC3H6O3 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Bregagnollo EA, et al. Assessment of inotropic and vasodilating effects of milrinone lactate in patients with dilated cardiomyopathy and severe heart failure. Arq Bras Cardiol. 1999 Feb;72(2):149-60. [2]. Meyer S, et al. The role of milrinone in children with cardiovascular compromise: review of the literature. Wien Med Wochenschr. 2011 Apr;161(7-8):184-91. |
Milrinone lactate
CAS: 100286-97-3 F: C12H9N3O.xC3H6O3 W:
Milrinone lactate is a potent inotropic dilating agent. Milrinone lactate shows simultaneous positive inotropic and vaso
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.